Reckitt Benckiser(US:RBGLY) Prnewswire·2025-07-22 12:45Core Viewpoint - A class action securities lawsuit has been filed against Reckitt Benckiser Group plc, alleging securities fraud that negatively impacted investors between January 13, 2021, and July 28, 2024 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that Reckitt Benckiser's cow's milk-based formula, Enfamil, increased the risk of preterm infants developing NEC, which was not disclosed [2]. - It is alleged that the company misrepresented the impact of these risks on its sales and exposure to legal claims, leading to materially false and misleading statements about its business and prospects [2]. Group 2: Next Steps for Investors - Investors who suffered losses during the specified timeframe have until August 4, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require this [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees [3]. Group 3: Firm Background - Levi & Korsinsky has a history of securing hundreds of millions of dollars for shareholders and is recognized as one of the top securities litigation firms in the United States [4].